Breaking News Instant updates and real-time market news.

GLW

Corning

$31.21

0.37 (1.20%)

, T

AT&T

$29.82

0.41 (1.39%)

10:55
11/21/18
11/21
10:55
11/21/18
10:55

UBS optical/networking equip analyst to hold analyst/industry conference call

Optical & Networking Equipment Analyst Venkatesh discusses fiber requirements for 5G networks with Philippe Vanhille, EVP of Prysmian Group Telecom, Corning's primary competitor in selling fiber to AT&T and Verizon, on an Analyst/Industry conference call to be held on November 21 at 11:30 am.

GLW

Corning

$31.21

0.37 (1.20%)

T

AT&T

$29.82

0.41 (1.39%)

VZ

Verizon

$59.30

-0.16 (-0.27%)

  • 21

    Nov

  • 26

    Nov

  • 03

    Dec

GLW Corning
$31.21

0.37 (1.20%)

09/14/18
09/14/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. WELLS SAYS 'MAY BE AS GOOD AS IT GETS' FOR COSTCO: Wells Fargo analyst Edward Kelly downgraded Costco Wholesale to Market Perform from Outperform with an unchanged price target of $235. While Costco remains one of the highest quality companies within consumer and its near-term results should be positive, "this may be as good as it gets," Kelly told investors. He believes the stock's 50% rally over the past year "has left it priced for perfection" and that Costco's comps "seem destined to slow in 2019" as it laps tough comparisons. JPMORGAN ADVISE CAUTION ON GE: A read of the proxies for the General Electric (GE) and Wabtec (WAB) transportation deal suggests "caution is warranted" in taking the forecasts "to the bank," JPMorgan analyst Stephen Tusa wrote in a research note. The situation "looks eerily similar" to GE's Baker Hughes (BHGE) deal, where management went from pitching $8B in future EBITDA several years forward to "slowly pulling annual guidance once public," with a consensus that is now at $5B, Tusa said. He believes that as each of GE's Industrial businesses get broken out clearly with "clean GAAP" transparency, the less impressive the financials look. Tusa keeps an Underweight rating on General Electric shares. CORNING UPGRADED ON OPTICAL DEMAND STRENGTH: Citi analyst Asiya Merchant upgraded Corning (GLW) to Buy from Neutral with a $40 price target, telling investors that the shares are "poised to continue to grind higher" in the next 12-18 months. The analyst expects Corning's earnings and margins growth will be driving by optical demand strength and better display pricing. JPMORGAN CUTS VALVOLINE TO UNDERWEIGHT ON NEW AMAZON COMPETITION: JPMorgan analyst Jeffrey Zekauskas downgraded Valvoline (VVV) to Underweight from Neutral and lowered his price target for the shares to $20 from $22. Industry trade publication National Oil and Lube New is reporting that Amazon (AMZN) has launched its first private label motor oil called AmazonBasics Full Synthetic Motor Oil, Zekauskas noted. While too early to gauge the effects of the Amazon entry on the Valvoline brand, the new competition from Amazon will likely reduce Valvoline's trading multiple "because the lubricant industry structure is probably weaker for its entry," Zekauskas contends. NVIDIA TARGET HIKED TO $350: Needham analyst Rajvindra Gill raised his price target on Nvidia to $350 from $325 after his investor meeting with its Data Center GM and Director of IR, saying the discussions about the company's AI/ML dominance reminded him of "Wintel" platform during the PC computing era. The analyst believes that Nvidia is "uniquely positioned" to capitalize on the next wave of computing, taking a larger inference market share with its new TensorRT Hyperscaler Platform.
09/14/18
09/14/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Corning (GLW) upgraded to Buy from Neutral at Citi with analyst Asiya Merchant saying the shares are "poised to continue to grind higher" in the next 12-18 months as investors appreciate the company's "multiple vectors" for revenue growth, diversification and margin expansion. 2. Coca-Cola European Partners (CCE) was upgraded to Outperform at Wells Fargo and to Neutral from Negative at Susquehanna. 3. VF Corp. (VFC) upgraded to Outperform from Market Perform at Cowen with analyst John Kernan saying VF's disclosure of a 23% operating margin for Vans implies that the brand alone could generate $1B-plus in free cash flow by fiscal 2022. 4. Helmerich & Payne (HP) upgraded to Neutral from Underweight at JPMorgan with analyst Sean Meakim saying Helmerich exceeded his expectations in adapting to the upgrade cycle. 5. Parker-Hannifin (PH) upgraded to Buy from Neutral at Buckingham. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/20/18
ARGS
09/20/18
NO CHANGE
Target $42
ARGS
Buy
Corning price target raised to $42 from $36 at Argus
Argus analyst Jim Kelleher raised Corning's price target to $42 from $36 sayaing its positioned to leverage revenue growth into margin expansion in 2H 2018 and 2019. Kelleher said investments are now bearing fruit and is positioned for positive bottom-line comparisons for 2H 2018 and 2019.
11/14/18
GUGG
11/14/18
DOWNGRADE
GUGG
Neutral
Guggenheim sees 5% iPhone drop next year, downgrades Apple to Neutral
Guggenheim analyst Robert Cihra downgraded Apple to Neutral from Buy and removed his prior $245 price target for the shares. The stock closed yesterday down $1.94 to $192.23. The average selling price of the iPhone has increased a "dramatic" $220, or 40%, over the past 10 years, reflecting its "growing value to both consumer and business markets," Cihra tells investors in a research note. The analyst points out, however, that nearly half of that increase came in fiscal 2018 alone. This makes a "period of digestion now likely," Cihra writes in a note partially titled "ASPs No Longer Enough." The analyst believes Apple's growth via average selling price is now "widely known." The iPhone's nearly 60% contribution to revenue and profits is "looking like a headwind again," says Cihra. Following early supply chain cuts, exemplified by Corning's (GLW) "softer" Q4 gorilla glass guidance back in October and this week's warnings from 3D sensing laser supplier Lumentum (LITE) and LCD supplier Japan Display, the analyst now estimates iPhone units will decline 5% year-over-year in fiscal 2019. He cut his fiscal 2019 earnings per estimate for Apple to $12.97 from $13.41 and revenue estimate to $273B from $281B.
T AT&T
$29.82

0.41 (1.39%)

10/18/18
NEED
10/18/18
NO CHANGE
Target $17
NEED
Buy
Adtran price target lowered to $17 at Needham on Q3 revenue slip
Needham analyst Richard Valera nudged his price target on Adtran (ADTN) lower to $17 from $18 and also lowered his FY19 EPS view to 15c from 42c after its Q3 revenues came in "light due to an explainable slip out of shipments to NBN". The analyst also notes the management's more downbeat view of its G.Fast program with AT&T (T), along with a generally more muted outlook for next year. Valera keeps a Buy on Adtran however, stating that although the stock is setting new 52-week lows on a series of disappointments, its valuation multiple of 1.1-times enterprise value to expected 2018 sales is supportive of the rating.
10/22/18
TIGR
10/22/18
UPGRADE
TIGR
Buy
AT&T upgraded to Buy from Neutral at Tigress Financial
Tigress Financial analyst Ivan Feinseth upgraded AT&T to Buy saying the upcoming launch of its high-speed 5G wireless communication network and the integration of Time Warner's content "creates a significant investment opportunity." AT&T will "significantly benefit from its merger with Time Warner creating one of the media industry's largest and most dynamic companies," Feinseth tells investors in a research note.
10/22/18
10/22/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Intel (INTC) upgraded to Buy from Neutral at Nomura Instinet with analyst Romit Shah saying he believes Intel is a buy at current share levels. 2. AT&T (T) upgraded to Buy from Neutral at Tigress Financial with analyst Ivan Feinseth saying the upcoming launch of its high-speed 5G wireless communication network and the integration of Time Warner's content "creates a significant investment opportunity." 3. M&T Bank (MTB) upgraded to Overweight from Neutral at Piper Jaffray with analyst Kevin Barker saying this quarter, M&T's deposit base remained steady, its loan/deposit ratio declined and management felt confident the ratio would remain in the 95%-100% range for the foreseeable future. 4. Chipotle (CMG) upgraded to Outperform from Sector Perform at RBC Capital with analyst David Palmer saying while Q3 earnings may be "lackluster," he expects comps to improve from 4% to 6% through the second half of FY19 and raises his FY20 EPS vie to $16.30 from $15.86 on implied 3-turn multiple increase to 31-times forward earnings. 5. SAP (SAP) upgraded to Buy from Neutral at UBS with analyst Michael Briest saying the company deserves credit for sustaining 6%-10% underlying sales growth over the past 12 quarters, with "impressive" cloud growth at scale. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/05/18
UBSW
11/05/18
DOWNGRADE
Target $34
UBSW
Neutral
Viacom downgraded to Neutral on tough AT&T renewal at UBS
As reported previously, UBS analyst John Hodulik downgraded Viacom (VIAB) to Neutral from Buy. The analyst believes the company will face a tough renewal with AT&T (T) in the second half of of 2019. He said Viacom has a low viewership relative to affiliate revenues, a lack of "must have" content, and a lack of carriage on other vMVPDs. Hodulik lowered his price target to $34 from $38 on Viacom shares.
VZ Verizon
$59.30

-0.16 (-0.27%)

10/19/18
ROTH
10/19/18
NO CHANGE
Target $3
ROTH
Buy
Roth Capital sees Digital Turbine powering Verizon pre-installs of Netflix app
Roth Capital analyst Darren Aftahi said he believes Digital Turbine's (APPS) software is powering Verizon's (VZ) pre-installations of the Netflix (NFLX) app on Android phones, which he noted the streaming service partially attributed for its solid domestic subscriber add performance in Q3. The success Netflix has seen has the potential to expand to other carriers and markets and provide a tailwind for Digital Turbine, said Aftahi, who keeps a Buy rating and $3 price target on the shares.
10/23/18
MOFT
10/23/18
NO CHANGE
MOFT
Verizon more or less fairly valued, says MoffettNathanson
10/23/18
GUGG
10/23/18
INITIATION
Target $59
GUGG
Buy
Verizon assumed with a Buy at Guggenheim
Guggenheim analyst Mike McCormack assumed coverage of Verizon Communications with a Buy rating and unchanged price target of $59. The rating is unchanged from the prior analyst's coverage.
10/24/18
RHCO
10/24/18
NO CHANGE
Target $61
RHCO
Buy
Verizon price target raised to $61 from $58 at SunTrust
SunTrust analyst Greg Miller raised his price target on Verizon to $61 and kept his Buy rating after its "solid" Q3 results. The analyst notes that its core wireless operations were "solid", modestly outperforming expectations and making up for the weakness in the company's smaller wireline and Oath segments. Miller is also positive on the management's capital deployment and 5G upgrade cycle investment.

TODAY'S FREE FLY STORIES

APDN

Applied DNA Sciences

$1.08

0.02 (1.89%)

05:52
12/10/18
12/10
05:52
12/10/18
05:52
Hot Stocks
Applied DNA Sciences signs joint development agreement with Everledger »

Applied DNA Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

EQIX

Equinix

$386.76

-6.1 (-1.55%)

05:51
12/10/18
12/10
05:51
12/10/18
05:51
Upgrade
Equinix rating change  »

Equinix upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

DLR

Digital Realty

$115.80

-1.135 (-0.97%)

05:50
12/10/18
12/10
05:50
12/10/18
05:50
Upgrade
Digital Realty rating change  »

Digital Realty upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RSAIF

RSA Insurance

$0.00

(0.00%)

05:47
12/10/18
12/10
05:47
12/10/18
05:47
Upgrade
RSA Insurance rating change  »

RSA Insurance upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWDHF

Skyworth Digital

$0.00

(0.00%)

05:45
12/10/18
12/10
05:45
12/10/18
05:45
Downgrade
Skyworth Digital rating change  »

Skyworth Digital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$40.72

-2.17 (-5.06%)

05:44
12/10/18
12/10
05:44
12/10/18
05:44
Hot Stocks
Biohaven announces initial 'positive' results from ongoing rimegepant study »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$73.87

0.1 (0.14%)

, GSK

GlaxoSmithKline

$37.28

-0.125 (-0.33%)

05:42
12/10/18
12/10
05:42
12/10/18
05:42
Downgrade
Tesaro, GlaxoSmithKline rating change  »

Tesaro downgraded to…

TSRO

Tesaro

$73.87

0.1 (0.14%)

GSK

GlaxoSmithKline

$37.28

-0.125 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWARF

Norwegian Air Shuttle

$0.00

(0.00%)

05:40
12/10/18
12/10
05:40
12/10/18
05:40
Upgrade
Norwegian Air Shuttle rating change  »

Norwegian Air Shuttle…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASX

ASE Technology

$3.77

-0.06 (-1.57%)

05:39
12/10/18
12/10
05:39
12/10/18
05:39
Earnings
ASE Technology reports November revenue down 3.2% to $1.23B »

Reports November IC-atm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQT

EQT Corporation

$18.42

0.41 (2.28%)

05:38
12/10/18
12/10
05:38
12/10/18
05:38
Periodicals
Rice Energy brothers want to take over running EQT, WSJ reports »

Derek and Toby Rice, who…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

ALNY

Alnylam

$74.28

-5.45 (-6.84%)

05:37
12/10/18
12/10
05:37
12/10/18
05:37
Hot Stocks
Alnylam announces settlement with Silence Therapeutics »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$53.08

-0.16 (-0.30%)

05:36
12/10/18
12/10
05:36
12/10/18
05:36
Hot Stocks
Bristol-Myers enters new clinical collaboration with Vedanta Biosciences »

Bristol-Myers and Vedanta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Dec

  • 24

    Jan

  • 20

    May

QDEL

Quidel

$48.48

-12.835 (-20.93%)

05:35
12/10/18
12/10
05:35
12/10/18
05:35
Conference/Events
Quidel to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

IQ

iQIYI

$18.51

-1.34 (-6.75%)

, CHL

China Mobile

$49.28

0.61 (1.25%)

05:34
12/10/18
12/10
05:34
12/10/18
05:34
Hot Stocks
iQIYI signs partnership with China Mobile »

iQIYI (IQ) recently…

IQ

iQIYI

$18.51

-1.34 (-6.75%)

CHL

China Mobile

$49.28

0.61 (1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QDEL

Quidel

$48.48

-12.835 (-20.93%)

05:27
12/10/18
12/10
05:27
12/10/18
05:27
Recommendations
Quidel analyst commentary  »

Quidel shares likely flat…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

05:24
12/10/18
12/10
05:24
12/10/18
05:24
Hot Stocks
Roche CEO Daniel O'Day to step down, Genentech CEO William Anderson to succeed »

Roche (RHHBY) announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 24

    Dec

  • 18

    Mar

EA

Electronic Arts

$82.57

-1.29 (-1.54%)

05:22
12/10/18
12/10
05:22
12/10/18
05:22
Recommendations
Electronic Arts analyst commentary  »

Electronic Arts price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILD

Gilead

$68.17

-2.01 (-2.86%)

, RHHBY

Roche

$0.00

(0.00%)

05:21
12/10/18
12/10
05:21
12/10/18
05:21
Hot Stocks
Gilead appoints Roche CEO Daniel O'Day as CEO, chairman »

Gilead Sciences announced…

GILD

Gilead

$68.17

-2.01 (-2.86%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 24

    Dec

  • 18

    Mar

FIVE

Five Below

$95.53

-6.19 (-6.09%)

05:16
12/10/18
12/10
05:16
12/10/18
05:16
Upgrade
Five Below rating change  »

Five Below upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMXAY

Genmab

$0.00

(0.00%)

05:12
12/10/18
12/10
05:12
12/10/18
05:12
Upgrade
Genmab rating change  »

Genmab upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UCBJY

UCB

$0.00

(0.00%)

05:10
12/10/18
12/10
05:10
12/10/18
05:10
Upgrade
UCB rating change  »

UCB upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWTUY

Swedish Orphan Biovitrum

$0.00

(0.00%)

05:08
12/10/18
12/10
05:08
12/10/18
05:08
Upgrade
Swedish Orphan Biovitrum rating change  »

Swedish Orphan Biovitrum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOR

MorphoSys

$27.63

-0.105 (-0.38%)

, JNJ

Johnson & Johnson

$145.38

-0.52 (-0.36%)

05:06
12/10/18
12/10
05:06
12/10/18
05:06
Upgrade
MorphoSys, Johnson & Johnson rating change  »

MorphoSys upgraded to Buy…

MOR

MorphoSys

$27.63

-0.105 (-0.38%)

JNJ

Johnson & Johnson

$145.38

-0.52 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

SLG

SL Green Realty

$93.32

-2.41 (-2.52%)

05:02
12/10/18
12/10
05:02
12/10/18
05:02
Upgrade
SL Green Realty rating change  »

SL Green Realty upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMA

Comerica

$74.07

-1.04 (-1.38%)

04:59
12/10/18
12/10
04:59
12/10/18
04:59
Downgrade
Comerica rating change  »

Comerica downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.